CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.

24-2351

Overview

Case Number 24-2351
Filing Date 2024-09-24
Status Terminated
Termination Date 2025-03-14
Court Court of Appeals for the Federal Circuit (cafc)
Nature of Suit 830 Patent Infringement (Fed. Qst.)
Cause of Action 35:271 Patent Infringement

Parties

Defendant

AMGEN USA, INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

BIOCON BIOLOGICS INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

CELLTRION, INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

FORMYCON AG NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

MYLAN PHARMACEUTICALS INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

SAMSUNG BIOEPIS CO., LTD. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Defendant - Appellee

AMGEN INC. Operating Company

Represented By

15 Attorneys Listed

Brett Alan Postal

Direct: 202-783-6040, Rothwell, Figg, Ernst & Manbeck, P.C.

901 New York Ave., NW, Suite 900, East, Washington, DC 20001

Chanson Chang, -

Direct: 408-410-3935, Amgen Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320

Edward Anthony Figg, -

Direct: 202-783-6040, Rothwell, Figg, Ernst & Manbeck, P.C.

901 New York Ave., NW, Suite 900, East, Washington, DC 20001

Eric Michael Agovino, -

Direct: 805-447-0464, Amgen Inc., MS 25-5-A

One Amgen Center Drive, Thousand Oaks, CA 91320

Jeffrey A. Lamken, -

Direct: 202-556-2000, MoloLamken LLP

600 New Hampshire Ave. NW, Washington, DC 20037

Jennifer Nock

Direct: 202-783-6040, Rothwell, Figg, Ernst & Manbeck, P.C.

901 New York Ave., NW, Suite 900, East, Washington, DC 20001

John Labbe

Attorney

Kayvon Ghayoumi, -

Direct: 202-836-8021, MoloLamken LLP

600 New Hampshire Ave. NW, Suite 500, Washington, DC 20037

Kevin M. Flowers

Direct: 312-474-6300, Marshall, Gerstein & Borun LLP

233 South Wacker Drive, 6300 Willis Tower, Chicago, IL 60606-6357

Lucas M. Walker

Direct: 202-556-2017, MoloLamken LLP

600 New Hampshire Ave. NW, Suite 660, Washington, DC 20037

Pauline Pelletier, Attorney

Direct: 805-447-1000, Amgen Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320

Robert Kry, -

Direct: 202-556-2011, MoloLamken LLP

600 New Hampshire Ave. NW, Washington, DC 20037

Thomas Burns, -

Direct: 312-474-6300, Marshall, Gerstein & Borun LLP

233 South Wacker Drive, 6300 Willis Tower, Chicago, IL 60606-6357

Wendy A. Whiteford

Direct: 805-447-1008, Amgen Inc.

One Amgen Center Drive, Mailstop 28-2-C, Thousand Oaks, CA 91320

Plaintiff - Appellant

REGENERON PHARMACEUTICALS, INC. Operating Company

Represented By

13 Attorneys Listed

Adam Pan, Attorney

Direct: 202-434-5910, Williams & Connolly LLP

680 Maine Ave., SW, Washington, DC 20024

Andrew V. Trask

Direct: 202-434-5023, Williams & Connolly LLP

680 Maine Ave. SW, Washington, DC 20024

Arthur John Argall, III, -

Direct: 202-434-5000, Williams & Connolly LLP

680 Maine Ave. SW, Washington, DC 20024

Charles McCloud, Attorney

Direct: 202-434-5998, Williams & Connolly LLP

680 Maine Ave., SW, Washington, DC 20024

Christian Gladden-Sorensen, -

Direct: 202-434-5736, Williams & Connolly LLP

680 Maine Ave., SW, Washington, DC 20024

David I. Berl, Esq.

Direct: 202-434-5491, Williams & Connolly LLP

680 Maine Ave. SW, Washington, DC 20024

Elizabeth Weiswasser

Direct: 212-373-3243, Paul, Weiss, Rifkind, Wharton & Garrison LLP

1285 Ave. of the Americas, New York, NY 10019-6064

Jacob Hartman, -

Direct: 202-326-7900, Kellogg, Hansen, Todd, Figel & Frederick, P.L.L.C.

1615 M St., NW, Suite 400, Washington, DC 20036

Kathryn Schleckser Kayali

Direct: 202-434-5644, Williams & Connolly LLP

680 Maine Ave. SW, Washington, DC 20024

Priyata Patel, AT

Direct: 202-223-7300, Paul Weiss Rifkind Wharton & Garrison LLP

2001 K St, NW, Washington, DC 20006

Rhochelle Krawetz, -

Direct: 202-434-5072, Williams & Connolly LLP

680 Maine Ave. SW, Washington, DC 20024

Shaun Patrick Mahaffy

Williams & Connolly LLP

680 Maine Ave., SW, Washington, DC 20024

Thomas S. Fletcher

Direct: 202-434-5497, Williams & Connolly LLP

680 Maine Ave. SW, Washington, DC 20024

Court & Judges

Court

Court of Appeals for the Federal Circuit (cafc)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Motion to Strike / Sanctions 1

Key Dispositive Motions & Rulings

Motion to Strike / Sanctions Pending / Under Review
Confidential UNOPPOSED MOTION TO SEAL MOTION TO STRIKE AND NOTICE OF CORRECTION filed by Appellant Regeneron Pharmaceuticals, Inc. corresponding to Doc. No. [58...
Entry #59 • 2024-12-17 Document →

Docket Entries

(65 total)

Appeal docketed. [1034526] Fee/IFP is due on 10/08/2024. Entry of Appearance is due on 10/08/2024. Certificate of Interest is due on 10/08/2024. Docketing Statement is due on 10/08/2024. [JSP] [Entered: 09/24/2024 02:05 PM]

Entry #1 • 2024-09-24
1

Entry of Appearance for Kathryn S. Kayali; Arthur J. Argall III; Adam Pan; Christian Gladden-Sorensen; Rhochelle Krawetz; Elizabeth S. Weiswasser; Priyata Patel; Jacob E. Hartman as counsel for Appellant Regeneron Pharmaceuticals, Inc.. Service: 09/24/2024 by clerk. [1034530] [JSP] [Entered: 09/24/2024 02:11 PM]

Entry #2 • 2024-09-24
1

Certificate of Interest for Appellant Regeneron Pharmaceuticals, Inc.. Service: 09/24/2024 by clerk. [1034531] [JSP] [Entered: 09/24/2024 02:12 PM]

Entry #3 • 2024-09-24
1

Docketing Statement for the Appellant Regeneron Pharmaceuticals, Inc.. Service: 09/24/2024 by clerk. [1034532] [JSP] [Entered: 09/24/2024 02:13 PM]

Entry #4 • 2024-09-24
1

Notice of Related Case Information for Appellant Regeneron Pharmaceuticals, Inc.. Service: 09/24/2024 by clerk. [1034534] [JSP] [Entered: 09/24/2024 02:14 PM]

Entry #5 • 2024-09-24
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc